Skip to main content
. 2016 Dec 8;6:38728. doi: 10.1038/srep38728

Figure 4. WE mitigates adverse LV remodelling after MI in the SILR model.

Figure 4

(a) Design of the SILR experiments with a WE dose of 400 mg/kg/day. (b) Representative sections stained with haematoxylin-eosin staining (top), and infarct size (bottom). (c) Representative sections stained with Sirius red (top), and collagen content presented as the stained area/left ventricular (LV) area. (d) Average LV wall thickness. (e) Expansion index. *P < 0.05, **P < 0.01, ***P < 0.001 compared with the controls. The numbers inside bars indicate the number of animals per group.